Dalla, Christina, Jaric, Ivana, Pavlidi, Pavlina, Hodes, Georgia E, Kokras, Nikolaos, Bespalov, Anton, Kas, Martien J, Steckler, Thomas, Kabbaj, Mohamed, Würbel, Hanno, Marroco, Jordan, Tollkuhn, Jessica, Shansky, Rebecca, Bangasser, Debra, Becker, Jill B, McCarthy, Margaret, Ferland-Beckham, Chantelle (October 2023) Practical solutions for including Sex As a Biological Variable (SABV) in preclinical neuropsychopharmacological research. Journal of Neuroscience Methods. p. 110003. ISSN 0165-0270
Preview |
PDF
2023_Practical_solutions_for_including_sex.pdf - Published Version Available under License Creative Commons Attribution. Download (10MB) | Preview |
Abstract
Recently, many funding agencies have released guidelines on the importance of considering sex as a biological variable (SABV) as an experimental factor, aiming to address sex differences and avoid possible sex biases to enhance the reproducibility and translational relevance of preclinical research. In neuroscience and pharmacology, the female sex is often omitted from experimental designs, with researchers generalizing male-driven outcomes to both sexes, risking a biased or limited understanding of disease mechanisms and thus potentially ineffective therapeutics. Herein, we describe key methodological aspects that should be considered when sex is factored into in vitro and in vivo experiments and provide practical knowledge for researchers to incorporate SABV into preclinical research. Both age and sex significantly influence biological and behavioral processes due to critical changes at different timepoints of development for males and females and due to hormonal fluctuations across the rodent lifespan. We show that including both sexes does not require larger sample sizes, and even if sex is included as an independent variable in the study design, a moderate increase in sample size is sufficient. Moreover, the importance of tracking hormone levels in both sexes and the differentiation between sex differences and sex-related strategy in behaviors are explained. Finally, the lack of robust data on how biological sex influences the pharmacokinetic (PK), pharmacodynamic (PD), or toxicological effects of various preclinically administered drugs to animals due to the exclusion of female animals is discussed, and methodological strategies to enhance the rigor and translational relevance of preclinical research are proposed.
| Item Type: | Paper |
|---|---|
| Subjects: | organism description > animal organism description > animal behavior organism description > animal > mammal organism description > animal > mammal > rodent > mouse neurobiology neurobiology > neuroscience organism description > animal > mammal > rodent organism description > animal behavior > sex differences neurobiology > neuroscience > systems neuroscience |
| CSHL Authors: | |
| Communities: | CSHL labs > Tollkuhn lab |
| SWORD Depositor: | CSHL Elements |
| Depositing User: | CSHL Elements |
| Date: | 31 October 2023 |
| Date Deposited: | 10 Nov 2023 14:11 |
| Last Modified: | 11 Apr 2024 13:58 |
| PMCID: | PMC10842858 |
| Related URLs: | |
| URI: | https://repository.cshl.edu/id/eprint/41307 |
Actions (login required)
 |
Administrator's edit/view item |